Speakers

  • Jón Ingi Bergsteinsson, Denmark I Congress Chair

    Jón Ingi Bergsteinsson, Denmark I Congress Chair

    Jón Ingi Bergsteinsson, M.Sc. BIOMED ENG, is the co-founder and CTO of MEDEI ApS. He graduated from the Biomedial Engineering department at Aalborg University in Denmark, where he specialised in medical software development and informatics. During his years at the university, he was actively involved in different clinical trials, where he acted as both assistant investigator, software engineer consultant, and technician.
    Read More...
  • Mads Frost, Denmark

    Mads Frost, Denmark

    Mads Frost, PhD, is a Post Doc at the IT University of Copenhagen (ITU) where he works in the Pervasive Interaction Technology (PIT) lab. Prior to this, Dr. Frost completed his PhD, centered around designing personal health technologies, with MONARCA as an example of this.
    Read More...
  • Micael Johansson, Sweden

    Micael Johansson, Sweden

    Micael is a senior regulatory and quality consultant in his own company NIMIO, also co-founder in MEDQURE a course provider based in Denmark. He sits on the MEDEA board (for consultants) and consults to start ups as well as large companies. 
    Read More...
  • Mahesh Malneedi, USA

    Mahesh Malneedi, USA

    Mahesh Malneedi Co-founded MakroCare 1996 and DDi LLC in 2014 and serves as its President for both. Mr. Malneedi was instrumental in start up and growth of MakroCare (functional services and consulting support for R&D areas) and DDi (eclinical products and tech solutions for clinical trials).
    Read More...
  • William R. Marsh, UK

    William R. Marsh, UK

    William R. Marsh is a Senior Lecturer in the School of Electronic Engineering and Computer Science at Queen Mary University of London. His research interests are in medical decisions support and probabilistic modelling for risk management, with a focus on the practical application of Bayesian networks. 
    Read More...
  • Rob Nichols, UK

    Rob Nichols, UK

    Chief Commercial Officer, Algorics
    Rob Nichols is the Chief Commercial Officer at Algorics, a provider of innovative clinical analytics solutions and software to the global life sciences industry.  Rob has had extensive experience in the eClinical industry, with senior leadership roles at DATATRAK, Phase Forward, Oracle and Quintiles.  
    Read More...
  • Mark Paul, USA

    Mark Paul, USA

    Senior Vice President North America, CROS NT
    Mark has served in progressive management positions in the clinical trials industry for over 25 years. In addition, Mark occupied the role of CEO of StatWorks, Inc., a data and biometrics focused CRO, for over 8 years. In his most recent role before joining CROS NT, Mark was a Managing Partner and head of sales and marketing for Veracity Logic.
    Read More...
  • Puspita Roy, Singapore

    Puspita Roy, Singapore

    Puspita is Senior Data Manager at Danone Nutricia Research. She joined Danone in 2013 and was one of the pioneers to set-up Biometrics team in Singapore.  She holds Masters in Genetics and has over 12 years’ experience in clinical data management, having operated with pharmaceuticals and CROs. 

    Read More...
  • Shahryar Shaghaghi, USA

    Shahryar Shaghaghi, USA

    Shahryar Shaghaghi leads BDO’s Technology Advisory Services practice and is Head of BDO International Cybersecurity, having more than 25 years of experience providing information technology (IT), operations and risk management consulting services to global organizations. 
    Read More...
  • Rauha Tulkki-Wilke, Finland

    Rauha Tulkki-Wilke, Finland

    Rauha Tulkki-Wilke leads the development of new eCOA (electronic Clinical Outcome Assessment) solutions and services at CRF Health. Rauha has been with CRF Health since it was founded and has more than 13 years of experience with all that eCOA encompasses. 
    Read More...
  • Thomas Wilckens, Germany

    Thomas Wilckens, Germany

    Dr. Thomas Wilckens is a medical doctor and a serial entrepreneur. He serves as the CEO of InnVentis Ltd., with a focus on the convergence of multi-omics technologies with real-world clinical data and machine learning to enable Precision Medicine. 
    Read More...